Search

Your search keyword '"Van Roy, N"' showing total 381 results

Search Constraints

Start Over You searched for: Author "Van Roy, N" Remove constraint Author: "Van Roy, N"
381 results on '"Van Roy, N"'

Search Results

2. Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials

6. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

8. Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes (Nature Medicine, (2021), 27, 10, (1806-1817), 10.1038/s41591-021-01511-6)

9. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

11. Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRβ-HOXA rearrangement: a study of the Groupe Francophone de Cytogénétique Hématologique

12. The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review

13. Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN -Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group

14. Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19

15. Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19

18. Quality Improvement of Repair Interventions on Built Heritage : Verbeteren van de uitvoeringstechnische kwaliteit van ingrepen bij bouwkundig erfgoed

21. Quality Assessment of Genetic Markers Used for Therapy Stratification

22. Age-dependency of the prognostic impact of tumor genomics in localized resectable MYCN non-amplified neuroblastomas Report from the SIOPEN Biology Group on the LNESG Trials

23. MYC-containing amplicons in acute myeloid leukemia: Genomic structures, evolution, and transcriptional consequences

24. Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials

28. LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19

29. ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling

30. The stratified significance of a historic facade as a basis for a more durable conservation approach

31. Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: A retrospective international study

32. Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study). . 105:1940-1948,2011

34. CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol

36. PHF6 mutations in T-cell lymphoblastic leukemia

37. In vitro human embryonic stem cell hematopoiesis mimics MYB-independent yolk sac hematopoiesis

38. Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification

40. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia

41. MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia

42. MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia

43. Treatment of human embryos with the TGF inhibitor SB431542 increases epiblast proliferation and permits successful human embryonic stem cell derivation

44. Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

45. Modulation of Mir-449a Expression Decreases Cell Viability, Increases Apoptosis and Induces Differentiation in Evi1 Deregulated Leukemia Cells

46. Identification and characterization of a novel member of the EXT gene family, EXTL2

47. The TCRB-HOXA rearrangement in T-ALL leads to a specific increase of the alternative HOXA10b transcript

48. Localization by fluorescence in situ hybridization of the human functional beta-glucuronidase gene (GUSB) to 7q11.21 to q 11.22 and two pseudogenes to 5p13 and 5q13

49. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma

Catalog

Books, media, physical & digital resources